J.D., George Mason University cum laude
Ph.D., Biological Chemistry, University of North Carolina - Chapel Hill
B.S., Chemistry, Berry College cum laude
District of Columbia
United States Patent and Trademark Office
United States Court of Appeals for the Federal Circuit
American Bar Association
American Chemical Society
American Intellectual Property Law Association
Dr. Gillentine is a Director in the Biotechnology/Chemical Group focused on the pharmaceutical industry. Because Dr. Gillentine is intimately familiar with the Hatch-Waxman Act and Biologics Price Competition and Innovation Act, and understands patent litigation strategy in the context of the statutory schemes and Patent Office Litigation, Dr. Gillentine is sought by both innovator and generic pharmaceutical companies for assistance with intellectual property issues related to their pharmaceutical products.
Dr. Gillentine has provided hundreds of patentability, noninfringement, and invalidity opinions. She has rendered opinions in at least the following areas: small molecules, therapeutic antibodies, polymorphs, salts, synthesis, pharmaceutical formulations, and pharmacokinetics.
Dr. Gillentine has also been admitted in multiple pharmaceutical patent litigations brought under the Hatch-Waxman Act.
Dr. Gillentine also assists clients in implementing lifecycle management strategies, including those for personalized medicine patent portfolios. Her practice encompasses both domestic and foreign patent prosecution, including patent drafting and patent prosecution. She has drafted and prosecuted patents related to various pharmaceutical issues. For example, Dr. Gillentine has prosecuted patents related to small molecules, polymorphs, chemical synthesis, pharmaceutical formulations, methods of treatment, drug delivery devices, animal models, vaccines, polymers, genes, gene expression systems, proteins, and antibodies.
Dr. Gillentine was one of the first recipients of the Sterne, Kessler, Goldstein & Fox Intellectual Property Scholarship at the George Mason University School of Law, where she was also a member of the Moot Court Board.
Unsolicited e-mails and information sent to Sterne, Kessler, Goldstein & Fox P.L.L.C. will not be considered confidential or privileged, may be disclosed to others, may not receive a response, and do not create an attorney-client relationship with Sterne Kessler. If you are not already a client of Sterne Kessler, do not include any confidential information in this message.